Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-015406

Options or other derivatives

  • Director acquired 16,985 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
FONTEYNE PAUL R. Director 2023-06-08 Grant or award · Stock Option (right to buy) +16,985 16,985 D
Loading xslF345X04/doc4.xml…